Purchase of 718,750 shares at $16 per share.
Reporting Person Rachlin Evan Lockwood · Transaction Code P
Traded Oct 16, 2026 · Disclosed Oct 19, 2026
Source: SEC Form 4 · 0002151678-26-000007 · filed 2026-10-19 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Iambic Therapeutics, Inc. (IAM)." Disclosed 2026-10-19. https://desqlong.com/cards/0002151678-26-000007-3 (retrieved 2026-10-20).